Clinical Epidemiology in Chronic Kidney Disease

Dear Colleagues,

Chronic kidney disease (CKD) is one of the major health problems worldwide, with an estimated prevalence of stages 1–4 of 16% in Europe and 13% in the US. Patients with end-stage kidney disease (ESKD) have an incredibly high risk of death and cardiovascular disease that is difficult to predict with Framingham risk factors.

Also, the high burden of comorbidities in this population of patients, including hypertension, diabetes, mineral bone disease, vascular calcification, endothelial dysfunction, coagulation abnormalities, accumulation of uremic toxins, increased oxidative and metabolic stress and inflammation, has an important impact on social and healthcare costs.

This Special Issue aims to collect original articles focused on the epidemiology of comorbidities, cardiovascular events, mineral bone disorders and other complications that can occur in chronic kidney disease patients.

We would like to pay special attention to novel therapies that impact various aspects of renal disease.

We invite researchers to contribute original articles or review articles about epidemiology of comorbidities or CV diseases and new therapies in CKD.

Potential topics include but are not limited to the following:

• Epidemiology of the onset and progression of CKD and/or ESRD;
• Epidemiology of cardiovascular complications in CKD and/or ESRD;
• Epidemiology of mineral bone disease in CKD and/or ESRD;
• Mechanisms shared between kidneys and other organs and/or diseases;
• New therapeutic strategies;
• Novel approaches in the epidemiology of comorbidities in CKD patients thanks to the use of Artificial Intelligence.

Dr. Vincenzo Antonio Panuccio
Dr. Claudia Torino
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• chronic kidney disease
• end-stage kidney disease
• dialysis
• hypertension
• renal disease
• clinical nephrology
• chronic renal failure